News

The recently published Clinical Practice Guidelines on metabolic dysfunction-associated steatotic liver disease (MASLD) was a joint effort of the European Association for the Study of the Liver (EASL), the E...

People living with diabetes have to make hundreds of decisions each day to manage their disease. Diabetes technology promises to ease this burden, but how effective is it in practice? This was one of the que...

Artificial intelligence is going to revolutionise also the medical field, especially when it comes to harnessing existing data sets for practical applications. A Swedish consortium has now published its appr...

While obesity is regarded a major risk factor for the development of type 2 diabetes, the causality of the association remains debated. With current therapies targeting both obesity and diabetes, the exchang...

Metformin is typically taken with meals to reduce gastrointestinal side effects. However, recent data indicate that administering metformin before meals can improve glycaemic control and that this is linked ...

New research suggests that hypoglycaemia during sleep may have been underestimated by up to 30% in previous studies. The results were obtained by using continuous glucose monitoring (CGM) in addition to cust...

More than half of all men with diabetes have impaired sexual health, most commonly due to erectile dysfunction. In women with diabetes, sexual dysfunction is less prevalent, but still occurs. In a joint sess...

Determining which treatment is suited best for specific patient groups can be a complex challenge. A recent study proposes a simple roadmap to guide clinicians through the interpretation of subgroup meta-ana...

Undiagnosed diabetes is a burgeoning problem. A recent study tested people for prediabetes and diabetes when they were admitted to A&E and preliminary findings were presented at the 59th Annual Meeting o...

People with type 1 and type 2 diabetes may need emergency treatment when hyperglycaemia gets out of hand. The American Diabetes Association (ADA), EASD and others have just updated their guidance on the mana...

Health disparities in diabetes care arise from many causes. A new study in a recent issue of Diabetologia uses the ACCORD trial to explore the influence of racial, ethnic and economic factors in achieving di...

One of the tasks that can be performed by artificial intelligence (AI) is diagnosing diabetic retinopathy from a retinal photograph with a performance that rivals that of a human grader. A new review in Diab...

Factors other than hyperglycaemia influence complications for both mother and baby in a pregnancy affected by type 1 diabetes. New metabolomic findings from the CONCEPTT trial, reported in Diabetologia, shed...

A number of drugs that mimic or enhance incretin agonism are now being used for glucose lowering in diabetes. They have proven cardiovascular safety and may even reduce cardiovascular complications. A new re...

A new population-based study, reported in a recent issue of Diabetologia, uses confocal microscopy to show that dysfunctional glucose metabolism is linked to corneal neurodegeneration. The findings suggest t...

Glucagon-like peptide-1 agonists have improved outcomes for people with type 2 diabetes in recent years with their glucose-lowering and weight-loss effects. This has fuelled interest in the therapeutic poten...

As rates of heart disease in diabetes fall thanks to improved prevention and treatment, cancer is coming to prominence as a complication and cause of excess death. However, a new paper in Diabetes Care repor...

The timing of moderate-to-vigorous exercise has an impact on HbA1c, with the afternoon hours being more favourable. This aspect of lifestyle intervention comes from the Look AHEAD trial in type 2 diabetes an...

While the recent 100th anniversary of the discovery of insulin was widely acknowledged in the diabetes community, much less attention has been paid to the centenary of its vital counter-regulatory hormo...

A new review in Diabetologia looks at how genetic risk scores are already being applied, both at the pre-clinical stages of type 1 diabetes and to more accurate classification of type 1, type 2 and other for...

A new study in Diabetologia finds that people with type 2 diabetes who are socioeconomically disadvantaged are less likely to be prescribed incretin-based therapies, including GLP-1 receptor agonists, even t...